Norethindrone Acetate

Quick links to important sections

Norethindrone Acetate

Selected form

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Norethindrone Acetate

Quick Facts

Property Description
Active ingredient Norethindrone Acetate (Norethisterone Acetate)
Form Oral tablet
Pharmacological class Synthetic Progestogen, Steroidal Hormone
Common use Hormonal regulation, Contraception
Origin Synthetic, derived from 19-nortestosterone

Norethindrone Acetate is a highly potent synthetic hormonal medication classified as a progestogen, a compound specifically engineered to chemically mimic the actions of the body's natural progesterone. It is the acetate ester of the base hormone, Norethindrone, and is provided exclusively as a prescription-only oral tablet for internal use. This structure, which originates from the 19-nortestosterone chemical base, is widely recognized in pharmacological studies for its stability and high oral effectiveness.


What Type of Medication is Norethindrone Acetate?

The medication belongs to the Progestogen pharmacological class, functioning as a specific progesterone receptor agonist. This means the active ingredient binds to and activates the body's progesterone receptors, signaling the reproductive system to respond as if it were receiving natural progesterone. The medication's enhanced stability and high potency contribute to its clinical recognition for establishing effectiveness in stabilizing and regulating essential female hormonal processes.


Form and Purpose: What is Norethindrone Acetate Used for?

The core purpose of Norethindrone Acetate is to provide a reliable progestational effect for comprehensive hormonal regulation. When administered as a single-entity oral tablet, its action suppresses the release of pituitary hormones, which in turn prevents key events of the menstrual cycle, most importantly, ovulation. This action establishes the drug's general utility in contraception and for stabilizing the uterine lining when managing conditions related to hormonal imbalance.


Composition and Administration Type

This medication is consistently provided as a single-entity product delivered via the oral route. The core component is the active ingredient, Norethindrone Acetate, combined with pharmaceutical excipients necessary to form the stable, defined structure of the tablet. Its primary positioning is as a strong, predictable progestogen, used across the world in generic formulations for women of reproductive age.

Regulatory References

  1. MedlinePlus Drug Information (Norethindrone)

What side effects are possible with Norethindrone Acetate?

Possible Side Effects and Safety Information

The official regulatory safety profile for Norethindrone Acetate is organized by the frequency and body system affected, based on data from sources like the FDA and SmPCs.


Frequency-Classified Adverse Reactions

The most commonly documented adverse reactions, classified as Common in regulatory labeling, often relate to the hormonal action of the drug. These include headache, nausea, breast tenderness, weight gain, and breakthrough bleeding or spotting. Depressed mood is generally classified as Uncommon.

Adverse effects are grouped into System-Organ Classes such as Reproductive system and breast disorders, Nervous system disorders, Gastrointestinal disorders, and Skin and subcutaneous tissue disorders (e.g., acne, alopecia).


Serious Adverse Reactions and Safety Constraints

Regulatory documents explicitly define the risk of rare but serious adverse reactions. These include Thromboembolic Disorders (e.g., blood clots in the legs or lungs) and the potential for the development of Hepatic Neoplasms (liver tumors).

The medication is contraindicated and subject to safety restrictions in the presence of impaired liver function or liver tumors, a history of thrombotic conditions, or undiagnosed abnormal genital bleeding. Furthermore, the drug is contraindicated during pregnancy due to the potential for fetal harm.

Irregular uterine bleeding is noted in official documents as being more frequent during the initial three months of use. Patients with pre-existing conditions like diabetes or those susceptible to fluid retention require close safety monitoring as documented in the product labeling.

Overdose and Emergency Response

Overdose and When to Seek Help

Norethindrone acetate has a generally low toxicity profile. Overdosage is not typically expected to be life-threatening and may present with characteristic symptoms related to its hormonal activity.

Documented Overdose Manifestations

Symptoms that may manifest in case of overdosage include:

  • Nausea and vomiting
  • Breast enlargement or tenderness
  • Vaginal bleeding, which may be delayed

Emergency Actions and Medical Attention

While there is generally no specific antidote, treatment for an overdose is focused on addressing the symptoms. In cases of very large or recent ingestion, procedural actions such as gastric lavage may be considered by a healthcare professional if the patient is seen within a few hours of exposure. This decision is based on clinical assessment, as no single course of action is required for all overdoses.

When to Contact a Professional

Always seek urgent medical attention or contact a poison control center immediately if a drug overdose is suspected. This is the necessary first step, even if the individual appears well or symptoms are mild. In the United States, the national toll-free Poison Help line is available for expert guidance.

Therapeutic Uses of Norethindrone Acetate

What Norethindrone Acetate Treats: Main Uses and Benefits

Norethindrone Acetate is a hormonal medication generally used to help with gynecological conditions and for contraception. The core therapeutic domains confirm its application in managing symptoms related to systemic hormonal imbalance and chronic reproductive disorders.

The primary uses include management of endometriosis, addressing secondary amenorrhea (absent periods), treating abnormal uterine bleeding due to hormonal imbalance, and pregnancy prevention.

Quick Fact: Relief for Disruptive Cycles

Symptom Targeted Primary Benefit
Heavy Menstrual Bleeding Contributes to easing symptoms related to heightened physiological activity.
Recurrent Pelvic Pain Supports general well-being during symptomatic phases.
Cycle Irregularity Assists with maintaining functional stability.

The medication is relevant in clinical settings for women of reproductive age when symptoms interfere with daily comfort or create noticeable physiological strain. It is commonly used when supportive symptom management is appropriate to address symptom clusters such as severe pain or unpredictable, excessive flow. This provides support that helps ease the overall symptom burden, and may help patients cope more steadily with symptom fluctuations.

Eligibility and Restrictions for Use

The eligibility for using Norethindrone Acetate is strictly defined by regulatory labeling, outlining specific populations that may use the medicine and those for whom it is strictly contraindicated.

Absolute Contraindications (Must Not Use)

Norethindrone Acetate is contraindicated in patients with a known or suspected pregnancy, history of arterial or venous thromboembolic disease (such as stroke or deep vein thrombosis), known or suspected cancer of the breast, and markedly impaired liver function or active liver disease. Use is also prohibited in cases of undiagnosed abnormal genital bleeding.

Population Status Regulatory Rule
Pregnancy Contraindicated
Liver Disease Contraindicated
Breast Cancer History Contraindicated

Restricted and Non-Recommended Use

Use is not recommended in children or elderly women, as appropriate safety and efficacy studies have not been performed in the geriatric population. Furthermore, the medicine is not recommended during breastfeeding due to a lack of adequate infant risk data. Patients with certain conditions, including epilepsy, asthma, or cardiac/renal dysfunction, must use the medication only under careful observation due to the potential for fluid retention, as stated in the official labeling.

What should I know about interactions with other medicines?

The effectiveness and safety of Norethindrone Acetate may be significantly altered when taken with certain other medicines, especially those that affect the way the body processes hormones. This is primarily due to interactions with the Cytochrome P450 (CYP) enzyme system, particularly the CYP3A4 pathway, which metabolizes Norethindrone.

Impact of Other Medicines

  • Enzyme-Inducing Medicines: Drugs that induce, or speed up, the activity of liver enzymes (e.g., certain anticonvulsants like Phenytoin, Carbamazepine, Phenobarbital, or anti-infectives like Rifampicin) can dramatically lower the concentration of Norethindrone in the bloodstream. This reduction may lead to a loss of therapeutic effect, particularly when used for contraception.
  • Herbal Products: The herbal product St. John's Wort is also a known enzyme inducer that can decrease the efficacy of Norethindrone Acetate.
  • Enzyme-Inhibiting Medicines: Conversely, medicines that inhibit or slow down these enzyme systems (e.g., strong CYP3A4 inhibitors) can increase the blood levels of Norethindrone, potentially increasing the risk of adverse effects. Drugs that inhibit P-glycoprotein (P-gp) may also affect absorption and plasma levels.

Restricted Combinations

  • Hepatitis C Regimens: Co-administration with certain Hepatitis C combination products containing ombitasvir/paritaprevir/ritonavir, with or without dasabuvir, is generally restricted due to the potential for significant Alanine Aminotransferase (ALT) elevations in the liver.
  • Other Drug Interactions: Norethindrone Acetate can also affect the body's processing of other medicines, such as Cyclosporin, potentially leading to higher-than-desired levels of the co-administered drug.

Mechanism of Action

Norethindrone Acetate functions as a synthetic progestin that is rapidly hydrolyzed in vivo to the active compound, norethindrone.

Molecular and Cellular Mechanism

Norethindrone acts primarily as an agonist for the intracellular progesterone receptor (PR), which belongs to the nuclear receptor superfamily. Upon binding, the activated PR-ligand complex translocates into the nucleus where it acts as a transcription factor.

The complex binds to specific progesterone response elements (PREs) located on the promoters of target genes. This binding modulates gene transcription, specifically promoting or inhibiting the expression of genes involved in reproductive tissue function.

Downstream and System-Level Effects

In the hypothalamus and anterior pituitary, norethindrone exerts negative feedback. This feedback alters the pulsatile release of gonadotropin-releasing hormone (GnRH) from the hypothalamus and reduces the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary.

The resulting suppression of gonadotropin levels prevents the LH surge required for ovulation (anovulation). Additionally, norethindrone alters the physicochemical properties of the cervical mucus, increasing its viscosity, and induces changes in the endometrium (decidualization), altering its structure and reducing its proliferative response to estrogen.

Dosage and Administration Information

How to Use Norethindrone Acetate

Norethindrone Acetate is administered orally as a tablet. The specific dosing regimen, frequency, and duration of therapy are determined by the medical condition being treated.

Official Administration Guidelines

Guideline Instruction
Route of Administration Oral (by mouth).
Dosing Schedule Varies by condition. Examples include 2.5 mg to 10 mg daily for 5 to 10 days for secondary amenorrhea or abnormal uterine bleeding, or a starting dose of 5 mg daily for endometriosis, gradually increasing the dose.
Timing The tablet is typically taken once daily at the same time each day. The medicine is sometimes taken with food or after a meal to reduce the potential for stomach upset.
Age-Group Rules Dosing is specific to the indication. Use in children is generally not recommended for the labeled conditions.

Missed Dose Instructions

If a dose is missed, patients should follow a specific protocol to minimize disruption to the regimen. If a dose is forgotten, take it as soon as it is remembered. However, if it is near the time for the next scheduled dose, the missed dose should be skipped. Patients must not double the dose to make up for a missed tablet.

Procedural Context

Therapy may require adaptation based on the individual's therapeutic response. For instance, in the management of endometriosis, the daily dosage may be incrementally increased every two weeks until a maximum prescribed daily dose is reached. Progestin withdrawal bleeding often occurs within three to seven days after discontinuing a short course of therapy.

Recent Clinical Evidence

Endometriosis and Symptom Relief

Norethindrone acetate (NETA) is a synthetic progestin used in the management of endometriosis and other gynecologic conditions. Research focuses on its ability to reduce symptoms, particularly chronic pelvic pain and dysmenorrhea (painful periods).

  • Pain Reduction: Studies have evaluated NETA against other hormonal therapies, such as dienogest. A randomized controlled trial found that both NETA and dienogest significantly reduced pain scores over a 12-month period, with comparable results between the two groups. NETA, however, showed a significantly greater reduction in the size of endometrioma lesions in some findings.
  • Long-Term Use: Research examining five-year therapy with NETA (2.5 mg/day up to 5 mg/day) for rectovaginal endometriosis reported a significant decrease in chronic pelvic pain and deep dyspareunia (painful intercourse) compared to baseline. Over this extended period, most women who completed the study expressed satisfaction with the treatment.

Abnormal Uterine Bleeding (AUB) and Pharmacokinetics

Clinical evidence also supports the use of NETA in managing abnormal uterine bleeding associated with hormonal imbalance.

Area of Research Key Finding Nuance
Bleeding Cessation Short-term use of 10 mg/day NETA has demonstrated effectiveness in achieving rapid bleeding cessation in randomized trials.
Metabolism & Absorption NETA is rapidly converted to its active component, norethindrone, after oral administration. Pharmacokinetic studies are ongoing to compare the levels achieved by NETA used for gynecologic indications versus low-dose norethindrone used for contraception, particularly concerning the drug's half-life.

Overall, the research continues to explore the most effective dosing strategies and long-term profiles of NETA for various approved indications, maintaining its role as a key hormonal therapy.

Frequently Asked Questions (FAQ)

Common questions about Norethindrone Acetate (FAQ)

Q: Is Norethindrone Acetate a type of birth control?

A: Norethindrone Acetate is a synthetic progestogen indicated for treating conditions like abnormal uterine bleeding and endometriosis. The official regulatory labeling indicates its use for these gynecologic conditions; it is not currently labeled by the FDA as a primary method of contraception.

Q: Can you take Norethindrone Acetate if you have high blood pressure?

A: Official product information advises that patients with existing blood pressure issues, especially uncontrolled hypertension, should generally avoid similar hormonal combinations. If high blood pressure is well-controlled, close monitoring is required during therapy, as this medication may sometimes cause a rise in blood pressure. Patients should discuss their medical history with a healthcare provider to determine appropriateness of use.

Q: Is there a generic version of Norethindrone Acetate available?

A: Yes, Norethindrone Acetate is widely available in generic formulations from several different manufacturers. A generic medication contains the exact same active ingredient and strength as the brand-name product.

Q: Are there any foods or supplements to avoid while taking this medicine?

A: Regulatory documents primarily focus on interactions with other medicines and enzyme-inducing herbal products like St. John's Wort, which can lower the drug's effectiveness. Specific warnings about common foods or general supplements are typically not itemized in the main patient labeling.

Q: Is Norethindrone Acetate safe for women who are close to menopause?

A: Norethindrone Acetate is not generally indicated for women who are already postmenopausal. However, it can be prescribed for specific conditions, such as abnormal uterine bleeding, which may occur during the perimenopausal transition. Information regarding its use near or during menopause should be reviewed in the official product labeling.

Q: Why do some people experience hair loss while taking Norethindrone Acetate?

A: Official adverse reaction lists include loss of scalp hair (alopecia) as a potential side effect. This is because Norethindrone Acetate, as a synthetic progestin, possesses some androgenic activity (hormonal effects similar to male hormones), which can sometimes affect hair growth in susceptible individuals.

Q: Does Norethindrone Acetate have a known risk of blood clots?

A: Yes, official safety warnings explicitly state that the use of progestational drugs, including Norethindrone Acetate, has been associated with a potential risk of thromboembolic disorders (blood clots). For this reason, it is strictly contraindicated in patients with a history of these conditions.

Q: Does Norethindrone Acetate change sex drive?

A: Official regulatory documents list changes in libido (sexual desire) among the adverse reactions observed in some patients receiving progestogen therapy. This change can be an increase or a decrease in sex drive.

Q: Can breastfeeding mothers use Norethindrone Acetate?

A: Norethindrone Acetate is generally not recommended or is contraindicated during breastfeeding. The drug is known to be excreted into human milk, and regulatory guidance advises against its use due to a lack of sufficient data on potential infant risk.

Q: What if I vomit shortly after taking Norethindrone Acetate?

A: If you experience vomiting or severe diarrhea shortly after taking the tablet, the drug's absorption and effectiveness may be reduced. Official patient information often suggests protocols for managing such events. If the medication is poorly absorbed, the efficacy may be affected, which may require contacting a healthcare provider for review.

Q: Why is this medication sometimes prescribed for non-contraceptive reasons?

A: The medication is specifically indicated and approved for non-contraceptive purposes related to hormonal regulation. These include the treatment of conditions such as secondary amenorrhea (absent periods), endometriosis, and abnormal uterine bleeding.

Q: What happens to the menstrual cycle after stopping Norethindrone Acetate?

A: Official patient information notes that a progestin withdrawal bleeding (similar to a period) often occurs within three to seven days after stopping a short course of therapy. Subsequent cycles will vary based on the original indication for use.

Q: Is an increase in headaches common with Norethindrone Acetate?

A: Yes, headache is listed in regulatory documents as one of the most commonly documented adverse reactions experienced by patients taking Norethindrone Acetate. This is an expected side effect related to hormonal changes.

Q: Can teenagers be prescribed Norethindrone Acetate?

A: Norethindrone Acetate is generally not indicated for use in children. If considering use in an adolescent, especially one who has not yet reached menarche (first menstrual period), specific caution is advised based on the official product information.

Q: Does smoking make Norethindrone Acetate less effective or more risky?

A: Official warnings for similar hormonal products highlight that smoking, particularly in women over 35, significantly increases the risk for thrombotic disorders (blood clots). While NETA is not a combined pill, this increased risk is a general safety concern with hormonal therapies.

Q: How reliable is Norethindrone Acetate for stopping a heavy period?

A: Clinical evidence reviewed in regulatory documents supports the drug's use in managing abnormal uterine bleeding. Studies show its effectiveness in achieving rapid bleeding cessation when used for short-term control of heavy or irregular bleeding.

Q: Is it true that Norethindrone Acetate can sometimes worsen acne?

A: Acne is listed among the adverse reactions that have been observed in patients taking the medication. Therefore, it is officially recognized as a potential side effect, and can sometimes present as a worsening of pre-existing skin conditions.

Q: Why do doctors often start with a low dose of Norethindrone Acetate?

A: Official dosage and administration guidelines emphasize that therapy must be adapted to the specific condition being treated and the individual's therapeutic response. Starting at a lower dose and adjusting is a common strategy to maximize effectiveness while minimizing adverse effects.

Q: Does Norethindrone Acetate affect the results of blood tests?

A: Yes, regulatory documents note that Norethindrone Acetate may alter the results of certain laboratory tests. This includes potential effects on some blood coagulation (clotting) tests and thyroid function tests.

Q: How is Norethindrone Acetate different from regular Norethindrone?

A: Norethindrone Acetate is a synthetic progestin that is rapidly converted to the active compound, norethindrone, in the body. The 'acetate' formulation is generally used in higher strengths for gynecologic conditions like endometriosis and bleeding, while lower-dose, non-acetate Norethindrone is often used for contraceptive pills.

Q: How quickly does Norethindrone Acetate start working for heavy bleeding?

A: Clinical studies have shown that short-term use of this medication is effective in achieving rapid cessation of bleeding. While the exact timeframe varies by individual, the goal is often rapid relief from heavy or abnormal uterine bleeding.

Q: How long can a person safely stay on Norethindrone Acetate?

A: Regulatory supporting research documents mention studies examining extended use, such as five-year therapy for endometriosis. The duration of use should align with the treated condition and may necessitate ongoing evaluation of safety and effectiveness.

Q: Can older women take Norethindrone Acetate for menopausal symptoms?

A: Use in elderly women is not recommended as appropriate safety and efficacy studies in the geriatric population have not been performed. Its role as the progestin component of combined hormone replacement therapy requires clinical evaluation of the risks and benefits.

Q: What are the serious but rare side effects of Norethindrone Acetate?

A: Official safety documents define serious, rare adverse effects which include thromboembolic disorders (blood clots in the legs or lungs) and the potential development of hepatic neoplasms (liver tumors). If signs or symptoms of serious adverse effects occur, prompt medical review is warranted.

How should Norethindrone Acetate be stored and disposed of?

How to Store and Dispose of Norethindrone Acetate

Norethindrone Acetate tablets must be stored at Controlled Room Temperature, which is defined as 20 C to 25 C (68 F to 77 F). The medication must be actively protected from both light and moisture.

Storage and Protection Rules

  • Container: Store the tablets in the original, tightly closed container.
  • Safety: The product must always be kept out of the reach of children.

Disposal Instructions

Unused or expired tablets should be disposed of according to local regulations. Regulatory guidance recommends consulting a pharmacist or taking advantage of community drug take-back programs. If using household disposal, the medicine should be mixed with an unappealing substance (like dirt or cat litter) and placed in a sealed bag before being thrown in the trash. The tablets must not be flushed down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Norethindrone Acetate found in:

A-Z Index: